Synthesis and anticancer properties of celastrol derivatives involved in the inhibition of VEGF

In this study, fourteen celastrol derivatives (1–14) were synthesised by esterification of celastrol at the 29th position. The in vitro anticancer activity of them was determined by the MTT assay. All the synthetic compounds showed significant antiproliferative activity against six cancer cells, wit...

Full description

Bibliographic Details
Main Authors: Mingxia Song, Jiantao Wen, Yi Hua, Yangnv Zhu, Qishan Xia, Qiaoyue Guo, Yiqin Luo, Xianqing Deng, Yushan Huang
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Journal of Enzyme Inhibition and Medicinal Chemistry
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/14756366.2023.2238137
_version_ 1827123347529400320
author Mingxia Song
Jiantao Wen
Yi Hua
Yangnv Zhu
Qishan Xia
Qiaoyue Guo
Yiqin Luo
Xianqing Deng
Yushan Huang
author_facet Mingxia Song
Jiantao Wen
Yi Hua
Yangnv Zhu
Qishan Xia
Qiaoyue Guo
Yiqin Luo
Xianqing Deng
Yushan Huang
author_sort Mingxia Song
collection DOAJ
description In this study, fourteen celastrol derivatives (1–14) were synthesised by esterification of celastrol at the 29th position. The in vitro anticancer activity of them was determined by the MTT assay. All the synthetic compounds showed significant antiproliferative activity against six cancer cells, with IC50 of the submicron molar level. The most promising compound (2) blocked the cell cycle in the G2 phase and inhibited the expression of VEGF and MMP-9 in gastric cancer cell line MGC-803. In flow cytometry analysis, compound 2 induced cancer cell apoptosis in a dose-dependent manner. In the mouse tumour xenograft model, compound 2 showed significant anti-tumour activity in vivo at the dosage of 2.5 mg/kg and 1 mg/kg, with a higher inhibition rate than 5-FU (10 mg/kg). What’s more, the anticancer mechanism involved in the inhibition of VEGF and the toxicity evaluation of compound 2 were also investigated.
first_indexed 2024-03-09T02:02:51Z
format Article
id doaj.art-73c155fcb7664122aa9fa1c4c1594b74
institution Directory Open Access Journal
issn 1475-6366
1475-6374
language English
last_indexed 2025-03-20T14:23:29Z
publishDate 2023-12-01
publisher Taylor & Francis Group
record_format Article
series Journal of Enzyme Inhibition and Medicinal Chemistry
spelling doaj.art-73c155fcb7664122aa9fa1c4c1594b742024-09-09T17:23:19ZengTaylor & Francis GroupJournal of Enzyme Inhibition and Medicinal Chemistry1475-63661475-63742023-12-0138110.1080/14756366.2023.2238137Synthesis and anticancer properties of celastrol derivatives involved in the inhibition of VEGFMingxia Song0Jiantao Wen1Yi Hua2Yangnv Zhu3Qishan Xia4Qiaoyue Guo5Yiqin Luo6Xianqing Deng7Yushan Huang8Affiliated Hospital of Jinggangshan University, Center for Clinical Medicine Research of Jinggangshan University, Jinggangshan University, Ji’an, Jiangxi, ChinaAffiliated Hospital of Jinggangshan University, Center for Clinical Medicine Research of Jinggangshan University, Jinggangshan University, Ji’an, Jiangxi, ChinaAffiliated Hospital of Jinggangshan University, Center for Clinical Medicine Research of Jinggangshan University, Jinggangshan University, Ji’an, Jiangxi, ChinaAffiliated Hospital of Jinggangshan University, Center for Clinical Medicine Research of Jinggangshan University, Jinggangshan University, Ji’an, Jiangxi, ChinaAffiliated Hospital of Jinggangshan University, Center for Clinical Medicine Research of Jinggangshan University, Jinggangshan University, Ji’an, Jiangxi, ChinaAffiliated Hospital of Jinggangshan University, Center for Clinical Medicine Research of Jinggangshan University, Jinggangshan University, Ji’an, Jiangxi, ChinaAffiliated Hospital of Jinggangshan University, Center for Clinical Medicine Research of Jinggangshan University, Jinggangshan University, Ji’an, Jiangxi, ChinaAffiliated Hospital of Jinggangshan University, Center for Clinical Medicine Research of Jinggangshan University, Jinggangshan University, Ji’an, Jiangxi, ChinaCenter for Evidence-Based Medical and Clinical Research, First Affiliated Hospital of Gannan Medical University, Ganzhou, ChinaIn this study, fourteen celastrol derivatives (1–14) were synthesised by esterification of celastrol at the 29th position. The in vitro anticancer activity of them was determined by the MTT assay. All the synthetic compounds showed significant antiproliferative activity against six cancer cells, with IC50 of the submicron molar level. The most promising compound (2) blocked the cell cycle in the G2 phase and inhibited the expression of VEGF and MMP-9 in gastric cancer cell line MGC-803. In flow cytometry analysis, compound 2 induced cancer cell apoptosis in a dose-dependent manner. In the mouse tumour xenograft model, compound 2 showed significant anti-tumour activity in vivo at the dosage of 2.5 mg/kg and 1 mg/kg, with a higher inhibition rate than 5-FU (10 mg/kg). What’s more, the anticancer mechanism involved in the inhibition of VEGF and the toxicity evaluation of compound 2 were also investigated.https://www.tandfonline.com/doi/10.1080/14756366.2023.2238137CelastrolanticancerantitumormodificationVEGF
spellingShingle Mingxia Song
Jiantao Wen
Yi Hua
Yangnv Zhu
Qishan Xia
Qiaoyue Guo
Yiqin Luo
Xianqing Deng
Yushan Huang
Synthesis and anticancer properties of celastrol derivatives involved in the inhibition of VEGF
Journal of Enzyme Inhibition and Medicinal Chemistry
Celastrol
anticancer
antitumor
modification
VEGF
title Synthesis and anticancer properties of celastrol derivatives involved in the inhibition of VEGF
title_full Synthesis and anticancer properties of celastrol derivatives involved in the inhibition of VEGF
title_fullStr Synthesis and anticancer properties of celastrol derivatives involved in the inhibition of VEGF
title_full_unstemmed Synthesis and anticancer properties of celastrol derivatives involved in the inhibition of VEGF
title_short Synthesis and anticancer properties of celastrol derivatives involved in the inhibition of VEGF
title_sort synthesis and anticancer properties of celastrol derivatives involved in the inhibition of vegf
topic Celastrol
anticancer
antitumor
modification
VEGF
url https://www.tandfonline.com/doi/10.1080/14756366.2023.2238137
work_keys_str_mv AT mingxiasong synthesisandanticancerpropertiesofcelastrolderivativesinvolvedintheinhibitionofvegf
AT jiantaowen synthesisandanticancerpropertiesofcelastrolderivativesinvolvedintheinhibitionofvegf
AT yihua synthesisandanticancerpropertiesofcelastrolderivativesinvolvedintheinhibitionofvegf
AT yangnvzhu synthesisandanticancerpropertiesofcelastrolderivativesinvolvedintheinhibitionofvegf
AT qishanxia synthesisandanticancerpropertiesofcelastrolderivativesinvolvedintheinhibitionofvegf
AT qiaoyueguo synthesisandanticancerpropertiesofcelastrolderivativesinvolvedintheinhibitionofvegf
AT yiqinluo synthesisandanticancerpropertiesofcelastrolderivativesinvolvedintheinhibitionofvegf
AT xianqingdeng synthesisandanticancerpropertiesofcelastrolderivativesinvolvedintheinhibitionofvegf
AT yushanhuang synthesisandanticancerpropertiesofcelastrolderivativesinvolvedintheinhibitionofvegf